Lulizumab
Product Specifications
CAS Number
2235419-62-0
Target
Immunology/Inflammation related
Related Pathways
Immunology/Inflammation
Bioactivity
Lulizumab, a humanized anti-CD28 recombinant antibody, functions as a selective CD28 blockade. By specifically targeting CD28 signaling, it inhibits T cell activation [1].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1330193-01 0.02 mg (E-Coli)
Recombinant Haemophilus ducreyi Tetraacyldisaccharide 4'-kinase (lpxK)
Ask
View Details 
MBS1330193-02 0.02 mg (Yeast)
Recombinant Haemophilus ducreyi Tetraacyldisaccharide 4'-kinase (lpxK)
Ask
View Details MBS1330193-03 0.1 mg (E-Coli)
Recombinant Haemophilus ducreyi Tetraacyldisaccharide 4'-kinase (lpxK)
Ask
View Details MBS1330193-04 0.1 mg (Yeast)
Recombinant Haemophilus ducreyi Tetraacyldisaccharide 4'-kinase (lpxK)
Ask
View Details 
MBS1330193-05 0.02 mg (Baculovirus)
Recombinant Haemophilus ducreyi Tetraacyldisaccharide 4'-kinase (lpxK)
Ask
View Details